Photrexa Viscous

Active Ingredient(s): Riboflavin 5'-Phosphate + Dextran
FDA Approved: * April 15, 2016
Pharm Company: * AVEDRO INC
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Photrexa Viscous Overview

Flavin mononucleotide (FMN), or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase as well as cofactor in biological blue-light photo receptors.[1] During the catalytic cycle, a reversible interconversion of the oxidized (FMN), semiquinone (FMNH•) and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN i...

Read more Photrexa Viscous Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Flavin_mononucleotide

Recent Photrexa Viscous Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Riboflavin 5'-Phosphate + Dextran
  • Solution: 0.146%
  • Solution/drops: 0.146%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Photrexa Viscous: (1 result)

Sorted by National Drug Code
  • 25357-022 Photrexa Viscous 1.46 mg/ml Ophthalmic Solution/ Drops by Avedro, Inc.

Drugs with one or more similar ingredients: (10 results)

Related Photrexa Viscous Topics:

Xylocaine Viscous
Red numbing liquid for possible use by friend with esophageal cancer? Not sure of correct spelling. ## This is dental an... 2 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA